Bullish
KalVista CCO Sweeny sells shares worth $49,845
KalVista Pharmaceuticals CCO Nicole Sweeny sold 1,861 shares of company stock for $49,845 on May 22, 2026, primarily to cover tax obligations related ...
KALV
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (1)
Bearish (0)
Latest KALV News
Bullish
Neutral
KalVista (NASDAQ: KALV) CDO logs RSU vesting and small tax-driven share sale
KalVista Pharmaceuticals' Chief Development Officer, Christopher Yea, reported exercising 3,750 restricted stock units (RSUs) and subsequently selling...
Research KALV on:
Ad Space